Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar 15;91(6):2171-5.
doi: 10.1073/pnas.91.6.2171.

Endosomal aspartic proteinases are required for invariant-chain processing

Affiliations

Endosomal aspartic proteinases are required for invariant-chain processing

M A Marić et al. Proc Natl Acad Sci U S A. .

Abstract

Immunogenic peptides are displayed in the context of class II histocompatibility proteins on the surface of antigen-presenting cells. Class II alpha and beta subunits bind the invariant chain (I-chain), a transmembrane glycoprotein which must dissociate prior to peptide presentation. Proteolytic release of I-chain in an acidic compartment is followed by class II alpha beta surface expression. Two distinct proteinases sequentially catalyze I-chain dissociation in B-lymphoblastoid cell lines. An aspartic proteinase initiates processing whereas a cysteine proteinase catalyzes the final stages of I-chain release. Inactivation of these enzymes prevents class II alpha beta maturation, demonstrating that acidic proteinases are essential for the generation of functional class II complexes. I-chain processing was localized to a dense endosomal compartment, suggesting this is the first site where class II alpha beta become accessible to peptides. I-chain fragments complexed with class II alpha beta accumulate in dense endosomes of B-lymphoblastoid cells treated with cysteine proteinase inhibitors. A signal for endosomal retention/targeting present in the cytoplasmic tail of these fragments may sequester class II alpha beta in this compartment until I-chain processing is complete.

PubMed Disclaimer

References

    1. Nature. 1991 Feb 21;349(6311):669-76 - PubMed
    1. J Immunol. 1991 Feb 1;146(3):920-7 - PubMed
    1. Nature. 1991 Sep 12;353(6340):167-70 - PubMed
    1. Annu Rev Immunol. 1991;9:707-44 - PubMed
    1. J Biol Chem. 1991 Nov 25;266(33):22091-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources